LP247821-4
Imipenem+Relebactam
Active
Description
Relebactam is a beta-lactamase inhibitor used in conjunction with imipenem for the treatment of Gram-negative bacterial infections. Relebactam is effective against class A and class C beta-lactamases and has been found to restore imipenem activity against some carbapenem-resistant strains of Klebsiella and Pseudomonas. PMID: 27503659 Source: Regenstrief LOINC
Basic Part Properties
- Part Display Name
- Imipenem+Relebactam
- Part Type
- Component (Describes the core component or analyte measured)
- Created On
- 2017-01-12
- Construct for LOINC Short Name
- Imi+Rel
LOINC Terminology Service (API) using HL7® FHIR® Get Info
Requests to this service require a free LOINC username and password. Below is a sample of the possible capabilities. See the LOINC Terminology Service documentation for more information.
- CodeSystem lookup
- https:
//fhir.loinc.org/CodeSystem/$lookup?system=http: //loinc.org&code=LP247821-4
Language Variants Get Info
| Tag | Language | Translation |
|---|---|---|
| es-ES | Spanish (Spain) | Imipenem+Relebactam |
| zh-CN | Chinese (China) | 亚胺培南+瑞雷巴坦 Synonyms: CAS 1174018-99-5; |
| it-IT | Italian (Italy) | Imipenem+Relebactam |
| nl-NL | Dutch (Netherlands) | imipenem + relebactam |
| fr-CA | French (Canada) | Imipénem+Relébactam |
LOINC Copyright
Copyright © 2024 Regenstrief Institute, Inc. All Rights Reserved. To the extent included herein, the LOINC table and LOINC codes are copyright